Immune control of food intake: Enteroendocrine cells are regulated by CD4+ T lymphocytes during small intestinal inflammation

Gut

Volumn 55, Issue 4, 2006, Pages 492-497

  McDermott, J R ^a   Leslie, F C ^a   D'Amato, M ^b   Thompson, D G ^a   Grencis, R K ^a   McLaughlin, J T ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b Rotta Research Laboratorium   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR ALPHA; LOXIGLUMIDE; NEUTRALIZING ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL COUNT; CELL SECRETION; CHOLECYSTOKININ BLOOD LEVEL; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG INHIBITION; DUODENUM; ENDOCRINE CELL; ENTERITIS; FOOD INTAKE; HYPOPHAGIA; IMMUNE RESPONSE; INTESTINE INFECTION; MALE; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SMALL INTESTINE; TH2 CELL; TRICHINELLA SPIRALIS; UPREGULATION;

ANIMALS; CELL COUNT; CHOLECYSTOKININ; CYTOKINES; DISEASE MODELS, ANIMAL; DUODENUM; EATING; EATING DISORDERS; ENTEROENDOCRINE CELLS; IMMUNOHISTOCHEMISTRY; INTERLEUKINS; INTESTINE, SMALL; MAST CELLS; MICE; MICE, INBRED BALB C; MICE, INBRED STRAINS; RECEPTORS, CHOLECYSTOKININ; TH2 CELLS; TRICHINELLA SPIRALIS; TRICHINOSIS;

EID: 33645112510     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2005.081752     Document Type: Article

References (40)

1. Rigaud D, Angel LA, Cerf M, et al. Mechanisms of decreased food intake during weight loss in adult Crohn's disease patients without obvious mabbsorption. J Clin Nutr 1994;60:775-81.
2. Gee MI, Grace MG, Wensel RH, et al. Protein-energy malnutrition in gastroenterology outpatients: increased risk in Crohn's disease. J Am Diet Assoc 1985;85:1466-74.
3. McHugh K, Castonguay TW, Collins SM, et al. Characterization of suppression of food intake following acute colon inflammation in the rat. Am J Physiol Gastrointest liver Physiol 1993;265:R1001-5.
4. Best L, Mclaughlin JT. 2005. Nutrients as regulators of endocrine and neuroendocrine secretion. Top Curr Genet 2004;7:79-111.
5. Jenny M, Uhl C, Roche C, et al. Neurogenin3 is differentially required for endocrine cell fate specification in the intestinal and gastric epithelium. EMBO J 2002;21:6338-47.
6. Schonhoff SE, Giel-Moloney M, Leiter AB. Minireview: development and differentiation of gut endocrine cells. Endocrinology 2004;145:2639-44.
7. Yang Q, Bermingham NA, Finegold MJ, et al. Requirement of Math1 for secretory cell lineage commitment in the mouse intestine. Science 2001;294:2155-8.
8. Lal S, McLaughlin J, Barlow J, et al. Cholecystokinin pathways modulate sensations induced by gastric distension in man. Am J Physiol Gastrointest Liver Physiol 2004;287:G72-9.
9. Leslie FC, Thompson DG, McLaughlin JT, et al. Plasma cholecystokinin concentrations are elevated in acute upper gastrointestinal infections. Q J Med 2003;96:870-1.
10. Garside P, Grencis RK, Mowat AM. T lymphocyte dependent enteropathy in murine Trichinella spiralis infection. Parasite Immunol 1992;14:217-25.
11. Alizadeh H, Murrell KD. The intestinal mast cell response to Trichinella spiralis infection in mast cell-deficient w/wv mice. J Parasitol 1984;70:767-73.
12. Lammas DA, Wakelin D, Mitchell LA, et al. Genetic influences upon eosinophilia and resistance in mice infected with Trichinella spiralis. Parasitology 1992;105:117-24.
13. McDermott JR, Bartram RE, Knight PA, et al. Mast cells disrupt epithelial barrier function during enteric nematode infection. Proc Natl Acad Sci U S A 2003;100:7761-6.
14. Donaldson LE, Schmitt E, Huntley JF, et al. A critical role for stem cell factor and c-kit in host protective immunity to an intestinal helminth. Int Immunol 1996;8:559-67.
15. Grencis RK, Hultner L, Else KJ. Host protective immunity to Trichinella spiralis in mice: activation of Th cell subsets and lymphokine secretion in mice expressing different response phenolypes. Immunology 1991;74:329-32.
16. Urban JF Jr, Schopf L, Morris SC, et al. Stat 6 signaling promotes protective immunity against Trichinella spiralis through a mast cell- and T cell-dependent mechanism. J Immunol 2000;164:2046-52.
17. Mohrs M, Ledermann B, Köhler G, et al. Differences between IL-4- and IL-4 receptor-deficient mice in chronic leishmaniasis reveal a protective role for IL-13 receptor signalling. J Immunol 1999;162:7302-8.
18. Noben-Trauth N, Kropf P, Muller I. Susceptibility to Leishmania major infection in interleukin-4-deficient mice. Science 1996;271:987-90.
19. McKenzie GJ, Bancroft A, Grencis RK, et al. A distinct role for interleukin-13 in Th2-cell-mediated immune responses. Curr Biol 1998;8:339-42.
20. Barbara G, Vallance BA, Collins SM. Persistent intestinal neuromuscular dysfunction after acute nematode infection in mice. Gastroenterology 1997;113:1224-32.
21. Ko RC, Fan L, Lee DL, et al. Changes in host muscles induced by excretory/secretory products of larval Trichinella spiralis and Trichinella pseudospiralis. Parasitology 1994;108:195-205.
22. Juanola C, Giralt M, Jimenez M, et al. Mucosal mast cells are involved in CCK disruption of MMC in the rat intestine. Am J Physiol Gastrointest Liver Physiol 1998;275:G63-7.
23. Hershey GK. IL-13 receptors and signaling pathways: an evolving web. J Allergy Clin Immunol 2003;111:677-90.
24. Moran TH, Kinzig KP. Gastrointestinal satiety signals II. Cholecystokinin. Am J Physiol Gastrointest Liver Physiol 2004;286:G183-8.
25. Zittel TT, Glatzle J, Kreis ME, et al. c-fos protein expression in the nucleus of the solitary tract correlates with cholecystokinin dose injected and food intake in rats. Brain Res 1999;846:1-11.
26. Chua AS, Bekkering M, Rovati LC, et al. Clinical efficacy and prokinetic effect of the CCK-A antagonist loxiglumide in nonulcer dyspepsia. Ann N Y Acad Sci 1994;713:451-3.
27. Kamal M, Wakelin D, Ouellette AJ, et al. Mucosal T cells regulate Paneth and intermediate cell numbers in the small intestine of T.spiralis-infected mice. Clin Exp Immunol 2001;126:117-25.
28. Cheng H, Leblond CP. Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. III. Entero-endocrine cells. Am J Anat 1974;141:503-19.
29. Faro CJ, Reidelberger RD, Palmer JM. Suppression of food intake is linked to enteric inflammation in nematode-infected rats. Am J Physiol Regul Integr Comp Physiol 2000;278:R118-24.
30. Rubin DC, Zhang H, Qian P, et al. Altered enteroendocrine cell expression in T cell receptor alpha chain knock-out mice. Microsc Res Tech 2000;51:112-20.
31. Sharma R, Schumacher U. The diet and gut microflora influence the distribution of enteroendocrine cells in the rat intestine. Experientia 1996;52:664-70.
32. Gershon M. Review article: serotonin receptors and transporters-roles in normal and abnormal gastrointestinal motility. Aliment Pharmacol Ther 2004;20(suppl 7):3-14.
33. Spiller R. Effects of serotonin on intestinal secretion and motility. Current Opin Gastroenterol 2001;17:99-103.
34. Freier S, Eran M, Alon Y, et al. Verapamil and furosemide prevent cholecystokinin-induced translocation of immunoglobulins in rat intestine. Dig Dis Sci 1991;36:1619-24.
35. Rozsa Z, Varro V. Mechanism of action of cholecystokinin on intestinal blood flow; interactions with opioid peptides and vasoactive intestinal peptide. Neuropeptides 1985;6:71-81.
36. Meyer BM, Werth BA, Beglinger C, et al. Role of cholecystokinin in regulation of gastrointestinal motor functions. Lancet 1989;2:12-15.
37. Drucker DJ, Lovshin J, Baggio L, et al. New developments in the biology of the glucagon-like peptides GLP-1 and GLP-2. Ann N Y Acad Sci 2000;921:226-32.
38. Chan MS. The global burden of intestinal nematodes-50 years on. Parasitol Today 1997;13:438-43.
39. Montressor A, Crompton DW, Gyrkos TW, et al. Helminth control in school age children. A guide for managers of control programmes. Geneva: WHO, 2002.
40. Newton SE, Munn EA. The development of vaccines against gastrointestinal nematode infections, particularly Haemonchus contortus. Parasitol Today 1999;15:116-22.